Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma

References

• KohlerBAWardEMcCarthyBJAnnual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous systemJ Natl Cancer Inst2011103971473621454908
   PubMedGoogle Scholar
• AndrewesCHHarisijadesSPropagation of myxoma virus in one-day old miceBr J Exp Pathol1955361182114351633
   PubMedGoogle Scholar
• BurnetFMMyxomatosis as a method of biological control against the Australian rabbitAm J Public Health Nations Health195242121522152613007863
   PubMed Web of Science ®Google Scholar
• FennerFAdventures with poxviruses of vertebratesFEMS Microbiol Rev200024212313310717311
   PubMed Web of Science ®Google Scholar
• GorskiJMizakBChrobocinskaMControl of rabbit myxomatosis in PolandRev Sci Tech19941338698797949359
   PubMed Web of Science ®Google Scholar
• JacksonEWDornCRSaitoJKMcKercherDGAbsence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosisNature196621150463133144381646
   PubMed Web of Science ®Google Scholar
• PignoletBBoullierSGelfiJSafety and immunogenicity of myxoma virus as a new viral vector for small ruminantsJ Gen Virol200889Pt 61371137918474552
   PubMed Web of Science ®Google Scholar
• MacNeillALMoldenhauerTDotyRMannTMyxoma virus induces apoptosis in cultured feline carcinoma cellsRes Vet Sci20129321036103822100245
   PubMed Web of Science ®Google Scholar
• SypulaJWangFMaYBellJMcFaddenGMyxoma virus tropism in human tumor cellsGene Ther Mol Biol20048103114
   Google Scholar
• WangFMaYBarrettJWDisruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrierNat Immunol20045121266127415502830
   PubMed Web of Science ®Google Scholar
• WooYKellyKJStanfordMMMyxoma virus is oncolytic for human pancreatic adenocarcinoma cellsAnn Surg Oncol20081582329233518454298
   PubMed Web of Science ®Google Scholar
• FranceMRThomasDLLiuJMcFaddenGMacNeillALRoyEJIntraventricular injection of myxoma virus results in transient expression of viral protein in mouse brain ependymal and subventricular cellsJ Gen Virol201192Pt 119519920861319
   PubMed Web of Science ®Google Scholar
• LunXYangWAlainTMyxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomasCancer Res200565219982999016267023
   PubMed Web of Science ®Google Scholar
• LunXQZhouHAlainTTargeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycinCancer Res200767188818882717875723
   PubMed Web of Science ®Google Scholar
• LunXAlainTZempFJMyxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycinCancer Res201070259860820068158
   PubMed Web of Science ®Google Scholar
• StanfordMMShabanMBarrettJWMyxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivoMol Ther2008161525917998900
   PubMed Web of Science ®Google Scholar
• ThomasDLDotyRTosicVMyxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumorsCancer Immunol Immunother201160101461147221656158
   PubMed Web of Science ®Google Scholar
• CocaSPerez-PiquerasJMartinezDThe prognostic significance of intratumoral natural killer cells in patients with colorectal carcinomaCancer19977912232023289191519
   PubMed Web of Science ®Google Scholar
• IshigamiSNatsugoeSTokudaKClinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancerCancer Lett2000159110310810974412
   PubMed Web of Science ®Google Scholar
• PagesFBergerACamusMEffector memory T cells, early metastasis, and survival in colorectal cancerN Engl J Med2005353252654266616371631
   PubMed Web of Science ®Google Scholar
• VillegasFRCocaSVillarrubiaVGPrognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancerLung Cancer2002351232811750709
   PubMed Web of Science ®Google Scholar
• LiuJWennierSReinhardMRoyEMacNeillAMcFaddenGMyxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbitsJ Virol200983115933593819279088
   PubMed Web of Science ®Google Scholar
• RiveraJTessarolloLGenetic background and the dilemma of translating mouse studies to humansImmunity20082811418199409
   PubMed Web of Science ®Google Scholar
• WatanabeHNumataKItoTTakagiKMatsukawaAInnate immune response in Th1- and Th2-dominant mouse strainsShock200422546046615489639
   PubMed Web of Science ®Google Scholar
• FidlerIJNicolsonGLOrgan selectivity for implantation survival and growth of B16 melanoma variant tumor linesJ Natl Cancer Inst1976575119912021003551
   PubMedGoogle Scholar
• BorgesMBKatoSEDamasoCRAccuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodiesBiologicals200836210511017892944
   PubMed Web of Science ®Google Scholar
• WangGBarrettJWStanfordMInfection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factorProc Natl Acad Sci U S A2006103124640464516537421
   PubMed Web of Science ®Google Scholar
• BarteeEMcFaddenGHuman cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-betaCytokine200947319920519640730
   PubMed Web of Science ®Google Scholar
• The Jackson LaboratoryJAX^® mice strain C57BL/6J (000664) phenotype and body weight information2012 Available from: http://jaxmice.jax.org/strain/000664.htmlAccessed April 16, 2012
   Google Scholar
• FuchsEJMatzingerPIs cancer dangerous to the immune system?Semin Immunol1996852712808956455
   PubMedGoogle Scholar
• MatzingerPThe danger model: a renewed sense of selfScience2002296556630130511951032
   PubMed Web of Science ®Google Scholar
• BreitbachCJPatersonJMLemayCGTargeted inflammation during oncolytic virus therapy severely compromises tumor blood flowMol Ther20071591686169317579581
   PubMed Web of Science ®Google Scholar
• FuXTaoLRiveraAXuHZhangXVirotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activityCancer Gene Ther2011181178579421869820
   PubMed Web of Science ®Google Scholar
• GroteDCattaneoRFieldingAKNeutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expressionCancer Res200363196463646814559838
   PubMed Web of Science ®Google Scholar
• ZhangYPatelBDeyAAttenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil functionJ Immunol201218831002101022180616
   PubMed Web of Science ®Google Scholar
• KimJHOhJYParkBHSystemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSFMol Ther200614336137016905462
   PubMed Web of Science ®Google Scholar
• LeeJHRohMSLeeYKOncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor modelCancer Gene Ther2010172737919629143
   PubMed Web of Science ®Google Scholar
• LiuTCHwangTParkBHBellJKirnDHThe targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinomaMol Ther20081691637164218628758
   PubMed Web of Science ®Google Scholar
• LunXChanJZhouHEfficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of gliomaMol Ther201018111927193620808290
   PubMed Web of Science ®Google Scholar
• VeraMRazquinNPrietoJMeleroIFortesPGonzalez-AseguinolazaGIntratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cellsMol Ther200512595095915921960
   PubMed Web of Science ®Google Scholar
• YiangGTHarnHJYuYLImmunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in miceJ Biomed Sci2009164719422685
   PubMed Web of Science ®Google Scholar
• YuYLWeiCWChenYLChenMHYiangGTImmunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expressionInt J Oncol201036236537020043070
   PubMed Web of Science ®Google Scholar
• StephensonKBBarraNGDaviesEAshkarAALichtyBDExpressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunityCancer Gene Ther201219423824622158521
   PubMed Web of Science ®Google Scholar
• EpardaudMElpekKGRubinsteinMPInterleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cellsCancer Res20086882972298318413767
   PubMed Web of Science ®Google Scholar
• SteelJCRamloganCAYuPInterleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 helpCancer Res20107031072108120086176
   PubMed Web of Science ®Google Scholar
• WuZXuYIL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activationJ Mol Cell Biol20102421722220671116
   PubMed Web of Science ®Google Scholar
• HarropRDruryNShinglerWVaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responsesClin Cancer Res20071315 Pt 14487449417671134
   PubMed Web of Science ®Google Scholar
• TilneyNLPatterns of lymphatic drainage in the adult laboratory ratJ Anat1971109Pt 33693835153800
   PubMed Web of Science ®Google Scholar
• Van den BroeckWDeroreASimoensPAnatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl miceJ Immunol Methods20063121–2121916624319
   PubMed Web of Science ®Google Scholar